Source: FinanzNachrichten

iOmx: EQS-News: iOmx Therapeutics AG: iOmx Therapeutics Receives Regulatory Approval of Clinical Trial Application for IOMX-0675

EQS-News: iOmx Therapeutics AG / Key word(s): Regulatory Approval iOmx Therapeutics Receives Regulatory Approval of Clinical Trial Application for IOMX-0675 15.04.2025 / 10:00 CET/CEST The issuer ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Apollon Papadimitriou's photo - CEO of iOmx

CEO

Apollon Papadimitriou

CEO Approval Rating

90/100